Ensysce Biosciences, Inc. 8-K

What Happened
Ensysce Biosciences, Inc. (ENSC) filed a Form 8-K on April 3, 2026 reporting that board member Curtis Rosebraugh submitted a resignation dated and effective April 1, 2026. Until his resignation, Dr. Rosebraugh served on the Board’s Nominating and Corporate Governance Committee.

Key Details

• Resignation dated and effective: April 1, 2026.
• Director: Curtis (Dr.) Rosebraugh.
• Committee membership: Nominating and Corporate Governance Committee prior to resignation.
• The resignation notice is attached to the filing as Exhibit 17; no replacement or new appointments were disclosed in this 8-K.

Why It Matters
A director resignation affects board composition and oversight of corporate governance matters. While the filing does not indicate any immediate financial impact, investors should note the change in governance personnel and watch for subsequent disclosures about any replacement or committee reassignments that could influence board oversight.